Novartis Stock Dips As Q4 Profit Misses View; Plans Buyback; Sees Growth In FY19

Shares of Novartis AG (NVS) were losing around 2 percent in the early morning trading in Switzerland after the drug major reported weak profit in its fourth quarter, and core earnings were below market estimates. Net sales, however, increased and topped analysts' view. Further, the company proposed higher dividend as well as up to 10 billion Swiss francs share repurchase program.

from RTT - Earnings http://bit.ly/2BcqS9l
via IFTTT